SOW
NTLA icon

State of Wyoming’s Intellia Therapeutics NTLA Stock Holding History

State of Wyoming’s Portfolio NTLA Stock Details NTLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$51.5K Buy
+3,042
New +$42.6K 0.01% 1688
2022
Q2 		– Sell
-6
Closed – – 2057
2022
Q1 		$0 Sell
6
-4
-40% -$339 ﹤0.01% 1956
2021
Q4 		$1K Sell
10
-24
-71% -$3.01K ﹤0.01% 1817
2021
Q3 		$5K Buy
+34
New +$5.15K ﹤0.01% 1090
2021
Q2 		– Sell
-5
Closed – – 1208
2021
Q1 		$0 Buy
+5
New +$336 ﹤0.01% 535

Other funds holding NTLA

ARK Investment Management
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
RA Capital Management
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
RP
Regeneron Pharmaceuticals Tarrytown, New York $177M AUM 9.82% 1-Year Est. Return

State of Wyoming's NTLA Position: Q2 2026 in Review

State of Wyoming opened a new position in Intellia Therapeutics (NTLA) in Q2 2026: 3,042 shares worth $51.5K. The stake represents 0.01% of the portfolio and ranks #1688 among its holdings. This is a return to the name: State of Wyoming previously reported a position in NTLA as recently as Q1 2022.

State of Wyoming first reported a position in NTLA in Q1 2021 and has held it in 5 quarters since. 328 funds tracked by Wall St. Rank hold NTLA as of Q2 2026.

  • State of Wyoming held 3,042 shares of Intellia Therapeutics worth $51.5K as of Q2 2026.
  • Intellia Therapeutics was a new State of Wyoming position in Q2 2026.
  • Intellia Therapeutics made up 0.01% of State of Wyoming's portfolio in Q2 2026, its #1688 holding.
  • State of Wyoming first reported a position in Intellia Therapeutics in Q1 2021 and has held it in 5 quarters since.
  • 328 funds tracked by Wall St. Rank held Intellia Therapeutics as of Q2 2026.

Based on State of Wyoming's 13F filing for Q2 2026, filed 6 Aug 2026.